Bernie Sanders is personally stopping Biden’s top medical research nominee — and he’s not budging

Hurdles faced by Biden's pick for NIH chief raises concerns about White House personnel strategy.

Sen. Bernie Sanders said in a recent interview that he began warning the Biden administration in January that he wanted more unilateral actions to slash drug prices. | Chris Carlson/AP PhotoWhen President Joe Biden nominated Monica Bertagnolli to run the National Institutes of Health, it seemed like a choice meant to make everyone happy.

Bertagnolli’s candidacy is stalled indefinitely, caught up in a standoff between the administration and Sen. Bernie Sanders over Biden’s drug pricing agenda. Biden has been without a permanent NIH director for a year-and-a-half, alarming medical research groups who believe it’s critical to have a confirmed leader ahead of looming budget negotiations on Capitol Hill — as well to provide stability at a time when public health agencies are under increasing political scrutiny.

No hearing has been held. Instead, Sanders insists he feels no pressure to move on Bertagnolli’s nomination as long his requests remain unmet, telling POLITICO “the public is probably more on my side.” “The President shares the Senator’s concerns on drug pricing,” the White House spokesperson said, calling the IRA “the most consequential law addressing the high cost of prescription drugs.”

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

politico /  🏆 381. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New sweet tea-inspired Alabama beer sold in cans with Kay Ivey dressed like Colonel SandersCans of a sweet tea-inspired beer produced by Huntsville microbrewery Chandlers Ford features a familiar face in a familiar suit — Alabama Gov. Kay Ivey drawn into dress inspired by KFC's spokesperson.
Read more »

Sanders Raises Fresh Concerns Over 'Outrageous' Price of New Alzheimer's Drug'Not only does the high price of Leqembi threaten Medicare's finances, it will also negatively impact seniors on fixed incomes suffering from Alzheimer’s who simply cannot afford to pay,' wrote SenSanders.
Read more »